• Pharma Wants Every Senior on Statin Drugs as Corporate Media Seeks to Silence Doctors Exposing the Cholesterol Myth

    Cholesterol-lowering statin drugs are a $100 billion-a-year industry. Lipitor was, by far, the most profitable drug in the history of mankind among all pharmaceutical products, let alone being the most profitable cholesterol drug before its patent expired at the end of 2011. Sales to date from this one particular cholesterol-lowering statin drug have exceeded $140 billion. After Lipitor’s patent expired at the end of 2011, the FDA issued its first warnings against statin drugs, which include: liver injury, memory loss, diabetes, and muscle damage, among others. Thousands of lawsuits against the maker of Lipitor followed. As we have reported many times over the years here at Health Impact News, the cholesterol theory of heart disease is not well-supported by science at all. In fact, much of the science states that cholesterol is an important part of our health, and contrary to popular belief, those with the highest levels of cholesterol actually live longer than those with lower levels of cholesterol in their blood. However, with such a large segment of the American population moving into their senior years, the pharmaceutical industry's attempt to keep seniors on cholesterol-lowering statin drugs continues unabated, and the largely pharma-funded corporate media is doing their part to silence doctors and other researchers who criticize the failed cholesterol theory of heart disease. Dr. Malcolm Kendrick, a Scottish doctor and the author of the book The Great Cholesterol Con, has had his entire Wikipedia entry deleted recently in an obvious attempt to silence him as a new study was just published to try and justify putting more seniors on statin drugs. Here are his comments on this "new" study.

    Read full story...

  • Pharma Wants Every Senior on Statin Drugs as Corporate Media Seeks to Silence Doctors Exposing the Cholesterol Myth

    Admin said:

    Cholesterol-lowering statin drugs are a $100 billion-a-year industry. Lipitor was, by far, the most profitable drug in the history of mankind among all pharmaceutical products, let alone being the most profitable cholesterol drug before its patent expired at the end of 2011. Sales to date from this one particular cholesterol-lowering statin drug have exceeded $140 billion. After Lipitor’s patent expired at the end of 2011, the FDA issued its first warnings against statin drugs, which include: liver injury, memory loss, diabetes, and muscle damage, among others. Thousands of lawsuits against the maker of Lipitor followed. As we have reported many times over the years here at Health Impact News, the cholesterol theory of heart disease is not well-supported by science at all. In fact, much of the science states that cholesterol is an important part of our health, and contrary to popular belief, those with the highest levels of cholesterol actually live longer than those with lower levels of cholesterol in their blood. However, with such a large segment of the American population moving into their senior years, the pharmaceutical industry's attempt to keep seniors on cholesterol-lowering statin drugs continues unabated, and the largely pharma-funded corporate media is doing their part to silence doctors and other researchers who criticize the failed cholesterol theory of heart disease. Dr. Malcolm Kendrick, a Scottish doctor and the author of the book The Great Cholesterol Con, has had his entire Wikipedia entry deleted recently in an obvious attempt to silence him as a new study was just published to try and justify putting more seniors on statin drugs. Here are his comments on this "new" study.

    If cholesterol lowering statin drugs don't help, what DOES cause blood clots that give someone a stroke or heart attack? Is there a way to deal with that? My doctor says my blood clots have been caused by my cholesterol being too high.

  • Pharma Wants Every Senior on Statin Drugs as Corporate Media Seeks to Silence Doctors Exposing the Cholesterol Myth

    Very well said. I wish all comments were as knowledgeable and clearly stated as yours. Thanks!

  • Pharma Wants Every Senior on Statin Drugs as Corporate Media Seeks to Silence Doctors Exposing the Cholesterol Myth

    Statins inhibit the synthesis of vitamin K2, Magnesium stimulates calcitonin to draw calcium out of soft tissues and put it where it belongs and K2 is what activates the matrix Gla protein that binds to calcium ions and the calcitonin which in turn helps protects arteries and tissues from calcification normally. In other words, statins inhibit activation of the process that would remove calcium from the arteries doing exactly the opposite to helping with plaque buildup. Statins also inhibit the biosynthesis of selenium containing proteins which can lead to congestive heart failure, reminiscent of the dilated cardiomyopathies seen with selenium deficiency. Mice in which the MGP gene was deleted died prematurely because of massive calcification of their tracheal cartilage and blood vessels. https://www.ncbi.nlm.nih.gov/pubmed/2565563 and https://www.ncbi.nlm.nih.gov/pubmed/11473740
    Further, by not helping to put calcium where it belongs lacking K2 to activate the process, a high calcium level will occur. A high calcium level impairs cell permeability. That means glucose and insulin cant then efficiently enter the cell which then increases the blood levels contributing further toward hyperglycemia and type 2 diabetes conditions. https://www.ncbi.nlm.nih.gov/pubmed/16249463 Lacking K2 would therefore allow excess calcium and why statins can then also can contribute toward diabetes. A low chromium and certain fats that impair cell permeability also can contribute. Calcium loses all its beneficial qualities and becomes displaced, insoluble (hard), and harmful to the body when there is not enough magnesium present in relation to calcium that helps regulates it with some K2. Too much calcium in the mitochondria of the cell and it dies, too much in arteries lead to plaque buildup.